Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:36:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, with a standard header and footer, indicating access to the study record is blocked.
    Difference
    18%
    Check dated 2026-09-20T19:44:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study document revision was updated to v3.6.6 with two new update dates (2026-08-24 and 2026-08-05) and a revised file size of 1.86MB, reflecting changes to the attached document and its metadata.
    Difference
    0.2%
    Check dated 2026-08-30T22:23:10.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 in place of Revision: v3.6.4. This indicates a software/markup update to the study page.
    Difference
    0.0%
    Check dated 2026-08-09T11:07:55.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or documentation. This update does not affect the study content or data.
    Difference
    0.0%
    Check dated 2026-07-25T18:02:14.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The revision label now reads v3.6.3 where it previously showed v3.6.2. This update reflects a small metadata version change and does not modify the study details.
    Difference
    0.0%
    Check dated 2026-07-04T13:35:46.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.